P

Prothena Corp
D

PRTA

15.090
USD
-0.09
(-0.59%)
مفتوح الان
حجم التداول
4,386
الربح لكل سهم
-2
العائد الربحي
-
P/E
-6
حجم السوق
811,973,766
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ALNY
    ALNY
    -4.625
    (-1.88%)
    240.880 USD
    B
    BLUE
    -0.76500
    (-9.01%)
    7.72500 USD
    BMY
    BMY
    -0.390
    (-0.68%)
    56.890 USD
    GILD
    GILD
    -0.060
    (-0.06%)
    92.510 USD
    I
    IMUX
    0.01500
    (1.46%)
    1.04000 USD
    I
    INCY
    0.280
    (0.41%)
    69.190 USD
    MRNA
    MRNA
    0.870
    (2.21%)
    40.230 USD
    REGN
    REGN
    9.69
    (1.38%)
    712.29 USD
    S
    SGEN
    0
    (0%)
    0.000000 USD
    VRTX
    VRTX
    -1.31
    (-0.33%)
    396.21 USD
    المزيد
الأخبار

العنوان: Prothena Corp

القطاع: Healthcare
الصناعة: Biotechnology
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).